CLINICAL_TRIALS
trial_result
· 2022-03-02
Clinical Trial Update: Radiation Therapy Alone for the Treatment of Stage 1 and 2 Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma [Phase 2]
Summary
Phase 2 trial evaluating radiation therapy alone for Stage 1 and 2 MALT lymphoma shows completed status with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Ann Arbor Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Ann Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Phase 2 | Status: COMPLETED | Results posted: 2022-03-02